ReviewPharmacotherapy2015
Vedolizumab for the treatment of moderately to severely active ulcerative colitis.
Parambir S Dulai et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
10 papers cite it
this papercites it
ReviewPharmacotherapy2015
Parambir S Dulai et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.